.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
McKesson
Deloitte
Medtronic
Merck
Teva
Cipla
Daiichi Sankyo
McKinsey
Fuji

Generated: November 22, 2017

DrugPatentWatch Database Preview

Patent Applications for SODIUM PHENYLBUTYRATE

« Back to Dashboard

US Patent Applications for SODIUM PHENYLBUTYRATE

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
► Subscribe► SubscribeCompositions and methods for the treatment of cystic fibrosis2001-02-15Abandoned -- Failure to Respond to an Office Action2002-05-20
► Subscribe► SubscribeTherapeutic approaches to diseases by suppression of the NURR subfamily of nuclear transcription factors2001-05-11Abandoned -- Failure to Respond to an Office Action2004-06-01
► Subscribe► SubscribeMICROPARTICLES2001-08-15Patented Case2003-12-11
► Subscribe► SubscribeTOPICAL AROMATIC FATTY ACID COMPOSITION2001-08-24Patented Case2003-03-06
► Subscribe► SubscribeCompositions and methods for treatment of cystic fibrosis2001-10-04Abandoned -- Failure to Respond to an Office Action2004-11-01
► Subscribe► SubscribeOral low dose butyrate compositions2001-09-19Abandoned -- Failure to Respond to an Office Action2003-11-05
► Subscribe► SubscribeDifferentiating agents for the treatment of inflammatory intestinal diseases2001-07-02Abandoned -- Failure to Respond to an Office Action2003-05-05
► Subscribe► SubscribeUse of retinoids plus histone deacetylase inhibitors to inhibit the growth of solid tumors2002-02-01Abandoned -- Failure to Respond to an Office Action2004-03-24
► Subscribe► SubscribeSingle nucleotide polymorphisms associated with interstitial lung disease2002-02-14Abandoned -- Failure to Respond to an Office Action2004-11-15
► Subscribe► SubscribeDEACETYLASE INHIBITORS2001-08-31Patented Case2003-04-03
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Chubb
Queensland Health
Farmers Insurance
US Department of Justice
Citi
Moodys
Chinese Patent Office
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot